ROCKVILLE, Md., Oct. 29, 2025 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial results for the third quarter ended September 30, 2025, and operational highlights. Listeners…
